 |
|
|
REFERENCES
151.
Coates DP, Monk CR, Prys-Roberts C, Turtle M:
Hemodynamic effects of infusions of the emulsion formulation of propofol during
nitrous oxide anesthesia in humans. Anesth Analg 66:64–70, 1987.
152.
Blouin R, Seifert H, Conrad P: Propofol significantly
depresses hypoxic ventilatory drive during conscious sedation. Anesthesiology 77:A1215,
1992.
153.
Conti G, Dell'Utri D, Vilardi V, et al: Propofol
induces bronchodilation in mechanically ventilated chronic obstructive pulmonary
disease (COPD) patients. Acta Anaesthesiol Scand 37:105–109, 1993.
154.
Mehr E, Hirshman C, Lindeman K: The effect of
halothane, propofol and thiopental on peripheral airway reactivity. Anesthesiology
77:A1212, 1992.
155.
Brown RH, Wagner EM: Mechanisms of bronchoprotection
by anesthetic induction agents: Propofol versus ketamine. Anesthesiology 90:822–828,
1999.
156.
Lin CC, Shyr MH, Tan PP, et al: Mechanisms underlying
the inhibitory effect of propofol on the contraction of canine airway smooth muscle.
Anesthesiology 91:750–759, 1999.
157.
Brown RH, Greenberg RS, Wagner EM: Efficacy of
propofol to prevent bronchoconstriction: Effects of preservative. Anesthesiology
94:851–855, discussion 6A, 2001.
158.
Basu S, Mutschler DK, Larsson AO, et al: Propofol
(Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen
tension during experimental septic shock. Resuscitation 50:341–348, 2001.
159.
Chang H, Tsai SY, Chang Y, et al: Therapeutic
concentrations of propofol protect mouse macrophages from nitric oxide-induced cell
death and apoptosis. Can J Anaesth 49:477–480, 2002.
160.
Kondo U, Kim SO, Murray PA: Propofol selectively
attenuates endothelium-dependent pulmonary vasodilation in chronically instrumented
dogs. Anesthesiology 93:437–446, 2000.
161.
Horibe M, Ogawa K, Sohn JT, Murray PA: Propofol
attenuates acetylcholine-induced pulmonary vasorelaxation: Role of nitric oxide
and endothelium-derived hyperpolarizing factors. Anesthesiology 93:447–455,
2000.
162.
Larsen R, Rathgeber J, Bagdahn A, et al: Effects
of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients.
A comparison with etomidate. Anaesthesia 43(Suppl):25-31, 1988.
163.
Vermeyen KM, Erpels FA, Janssen LA, et al: Propofolfentanyl
anaesthesia for coronary bypass surgery in patients with good left ventricular function.
Br J Anaesth 59:1115–1120, 1987.
164.
Patrick MR, Blair IJ, Feneck RO, Sebel PS: A
comparison of the haemodynamic effects of propofol ('Diprivan') and thiopentone in
patients with coronary artery disease. Postgrad Med J 61(Suppl 3):23–27, 1985.
165.
Stephan H, Sonntag H, Schenk HD, et al: Effects
of propofol on cardiovascular dynamics, myocardial blood flow and myocardial metabolism
in patients with coronary artery disease. Br J Anaesth 58:969–975, 1986.
166.
Coates D, Prys-Roberts C, Spelina K: Propofol
('Diprivan') by intravenous infusion with nitrous oxide: Dose requirements and hemodynamic
effects. Postgrad Med J 61(Suppl 3):76–79, 1985.
167.
Claeys MA, Gepts E, Camu F: Haemodynamic changes
during anaesthesia induced and maintained with propofol. Br J Anaesth 60:3–9,
1983.
168.
Van Aken H, Meinshausen E, Prien T, et al: The
influence of fentanyl and tracheal intubation on the hemodynamic effects of anesthesia
induction with propofol/N2
O in humans. Anesthesiology 68:157–163,
1988.
169.
Samuelson PN, Reves JG, Kouchoukos NT, et al:
Hemodynamic responses to anesthetic induction with midazolam or diazepam in patients
with ischemic heart disease. Anesth Analg 60:802–809, 1981.
170.
Rao S, Sherbaniuk RW, Prasad K, et al: Cardiopulmonary
effects of diazepam. Clin Pharmacol Ther 14:182–189, 1973.
171.
Samuelson PN, Lell WA, Kouchoukos NT, et al:
Hemodynamics during diazepam induction of anesthesia for coronary artery bypass grafting.
South Med J 73:332–334, 1980.
172.
Dhadphale P, Behrendt D, Jackson P: The effect
of diazepam on contractility in the intact human heart [abstract]. Paper presented
at the annual meeting of the American Society of Anesthesiology, 1977, New Orleans.
173.
Prakash R, Thurer R, Vargas A: Cardiovascular
effects of diazepam induction in patients for aortocoronary saphenous vein bypass
grafts [abstract]. Paper presented at the annual meeting of the American Society
of Anesthesiology, 1976.
174.
Jackson AP, Dhadphale PR, Callaghan ML, Alseri
S: Haemodynamic studies during induction of anaesthesia for open-heart surgery using
diazepam and ketamine. Br J Anaesth 50:375–378, 1978.
175.
Prys-Roberts C, Kelman GR: The influence of drugs
used in neuroleptanalgesia on cardiovascular and ventilatory function. Br J Anaesth
39:134–145, 1967.
176.
Israel J, Jansen G, Dobkin A: Circulatory and
respiratory response to tilt with pentazocine (Win 20, 228), droperidol (R4749),
droperidol-fentanyl (Innovar), and methotrimeprazine in normal healthy male subjects.
Anesthesiology 26:253, 1965.
177.
Colvin MP, Savege TM, Newland PE, et al: Cardiorespiratory
changes following induction of anaesthesia with etomidate in patients with cardiac
disease. Br J Anaesth 51:551–556, 1979.
178.
Gooding JM, Weng JT, Smith RA, et al: Cardiovascular
and pulmonary responses following etomidate induction of anesthesia in patients with
demonstrated cardiac disease. Anesth Analg 58:40–41, 1979.
179.
Gooding JM, Corssen G: Effect of etomidate on
the cardiovascular system. Anesth Analg 56:717–719, 1977.
180.
Kettler D, Sonntag H, Donath U, et al: Haemodynamics,
myocardial mechanics, oxygen requirement and oxygenation of the human heart during
induction of anaesthesia with etomidate [in German]. Anaesthesist 23:116–121,
1974.
181.
Tweed WA, Minuck M, Mymin D: Circulatory responses
to ketamine anesthesia. Anesthesiology 37:613–619, 1972.
182.
Tweed WA, Mymin D: Myocardial force-velocity
relations during ketamine anesthesia at constant heart rate. Anesthesiology 41:49–52,
1974.
183.
Nishimura K, Kitamura Y, Hamai R, et al: Pharmacological
studies of ketamine hydrochloride in the cardiovascular system. Osaka City Med J
19:17–26, 1973.
184.
Ruff R, Reves JG: Hemodynamic effects of a lorazepamfentanyl
anesthetic induction for coronary artery bypass surgery. J Cardiothorac Anesth 4:314–317,
1990.
185.
Lebowitz PW, Cote ME, Daniels AL, et al: Comparative
cardiovascular effects of midazolam and thiopental in healthy patients. Anesth Analg
61:771–775, 1982.
186.
Lebowitz P, Cote M, Daniels A: Cardiovascular
effects of midazolam and thiopentone for induction of anesthesia in ill surgical
patients. Can J Anaesth 30:19–23, 1983.
187.
Marty J, Nitenberg A, Blanchet F, et al: Effects
of midazolam on the coronary circulation in patients with coronary artery disease.
Anethesiology 64:206–210, 1986.
188.
Wahr JA, Plunkett JJ, Ramsay JG, et al: Cardiovascular
responses during sedation after coronary revascularization. Incidence of myocardial
ischemia and hemodynamic episodes with propofol versus midazolam. Institutions of
the McSPI Research Group. Anesthesiology 84:1350–1360, 1996.
189.
Graham MR, Thiessen DB, Mutch WA: Left ventricular
systolic and diastolic function is unaltered during propofol infusion in newborn
swine. Anesth Analg 86:717–723, 1998.
190.
Lejay M, Hanouz JL, Lecarpentier Y, et al: Modifications
of the inotropic responses to alpha- and beta-adrenoceptor stimulation by propofol
in rat myocardium. Anesth Analg 87:277–283, 1998.
191.
Pagel PS, Warltier DC: Negative inotropic effects
of propofol as evaluated by the regional preload recruitable stroke work relationship
in chronically instrumented dogs. Anesthesiology 78:100–108, 1993.
192.
Ebert T, Muzi M, Goff D: Does propofol really
preserve baroreflex function in humans? Anesthesiology 77:A337, 1992.
193.
Xuan YT, Glass PS: Propofol regulation of calcium
entry pathways in cultured A10 and rat aortic smooth muscle cells. Br J Pharmacol
117:5–12, 1996.
194.
Chang KS, Davis RF: Propofol produces endothelium-independent
vasodilation and may act as a Ca2+
channel blocker. Anesth Analg 76:24–32,
1993.
195.
Yamashita A, Kajikuri J, Ohashi M, et al: Inhibitory
effects of propofol on acetylcholine-induced, endothelium-dependent relaxation and
prostacyclin synthesis in rabbit mesenteric resistance arteries. Anesthesiology
91:1080–1089, 1999.
196.
Samain E, Bouillier H, Marty J, et al: The effect
of propofol on angiotensin II-induced Ca(2+) mobilization in aortic smooth muscle
cells from normotensive and hypertensive rats. Anesth Analg 90:546–552, 2000.
197.
Doursout MF, Joseph PM, Liang YY, et al: Role
of propofol and its solvent, Intralipid, in nitric oxide-induced peripheral vasodilatation
in dogs. Br J Anaesth 89:492–498, 2002.
198.
Ebert TJ, Muzi M, Berens R, et al: Sympathetic
responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology
76:725–733, 1992.
199.
Cullen PM, Turtle M, Prys-Roberts C, et al: Effect
of propofol anesthesia on baroreflex activity in humans. Anesth Analg 66:1115–1120,
1987.
200.
Kanaya N, Hirata N, Kurosawa S, et al: Differential
effects of propofol and sevoflurane on heart rate variability. Anesthesiology 98:34–40,
2003.
201.
Sharpe MD, Dobkowski WB, Murkin JM, et al: Propofol
has no direct effect on sinoatrial node function or on normal atrioventricular and
accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam
anesthesia. Anesthesiology 82:888–895, 1995.
202.
Horiguchi T, Nishikawa T: Heart rate response
to intravenous atropine during propofol anesthesia. Anesth Analg 95:389–392,
2002.
203.
Wu M: Propofol and the supraventricular tachydysrhythmias
in children. Anesth Analg 86:914, 1998.
204.
Ebert TJ, Muzi M: Propofol and autonomic reflex
function in humans. Anesth Analg 78:369–375, 1994.
205.
Ko SH, Yu CW, Lee SK, et al: Propofol attenuates
ischemia-reperfusion injury in the isolated rat heart. Anesth Analg 85:719–724,
1997.
206.
Kokita N, Hara A, Abiko Y, et al: Propofol improves
functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth
Analg 86:252–258, 1998.
207.
DeGrood P, VanEgmond J, VandeWetering M: Lack
of effects of emulsified propofol (Diprivan) on vecuronium pharmacodynamics: Preliminary
results in man. Postgrad Med J 61:28, 1985.
208.
Nightingale P, Petts NV, Healy TE, et al: Induction
of anaesthesia with propofol ('Diprivan') or thiopentone and interactions with suxamethonium,
atracurium and vecuronium. Postgrad Med J 61(Suppl 3):31–34, 1985.
209.
McKeating K, Bali IM, Dundee JW: The effects
of thiopentone and propofol on upper airway integrity. Anaesthesia 43:638–640,
1988.
210.
Richardson J: Propofol infusion for coronary
artery bypass surgery in a patient with suspected malignant hyperpyrexia. Anaesthesia
42:1125, 1987.
211.
Denborough M, Hopkinson KC: Propofol and malignant
hyperpyrexia. Lancet 1:191, 1988.
212.
Van Hemelrijck J, Weekers F, Van Aken H, et al:
Propofol anesthesia does not inhibit stimulation of cortisol synthesis. Anesth
Analg 80:573–576, 1995.
213.
Stark RD, Binks SM, Dutka VN, et al: A review
of the safety and tolerance of propofol (Diprivan). Postgrad Med J 61(Suppl 3):152–156,
1985.
214.
Robinson F: Propofol ('Diprivan') by intermittent
bolus with nitrous oxide in oxygen for body surface operations. Postgrad Med J 61(Suppl
3):116–119, 1985.
215.
Sear JW, Uppington J, Kay NH: Haemotological
and biochemical changes during anaesthesia with propofol ('Diprivan'). Postgrad
Med J 61(Suppl 3):165–168, 1985.
216.
Aviram M, Deckelbaum RJ: Intralipid infusion
into humans reduces in vitro platelet aggregation and alters platelet lipid composition.
Metabolism 38:343–347, 1989.
217.
Laxenaire MC, Mata-Bermejo E, Moneret-Vautrin
DA, Gueant JL: Life-threatening anaphylactoid reactions to propofol (Diprivan).
Anesthesiology 77:275–280, 1992.
218.
Doenicke A, Lorenz W, Stanworth D, et al: Effects
of propofol ('Diprivan') on histamine release, immunoglobulin levels and activation
of complement in healthy volunteers. Postgrad Med J 61(Suppl 3):15–20, 1985.
219.
McCollum JS, Milligan KR, Dundee JW: The antiemetic
action of propofol. Anaesthesia 43:239–240, 1988.
220.
Borgeat A, Wilder-Smith OH, Saiah M, Rifat K:
Subhypnotic doses of propofol relieve pruritus induced by epidural and intrathecal
morphine. Anesthesiology 76:510–512, 1992.
221.
Schulman SR, Rockett CB, Canada AT, Glass PS:
Long-term propofol infusion for refractory postoperative nausea: A case report
with quantitative propofol analysis. Anesth Analg 80:636–637, 1995.
222.
Gan TJ, Glass PS, Howell ST, et al: Determination
of plasma concentrations of propofol associated with 50% reduction in postoperative
nausea. Anesthesiology 87:779–784, 1997.
223.
Gan TJ, Ginsberg B, Grant AP, Glass PS: Double-blind,
randomized comparison of ondansetron and intraoperative propofol to prevent postoperative
nausea and vomiting. Anesthesiology 85:1036–1042, 1996.
224.
Borgeat A, WilderSmith O, Rifat K: Adjuvant propofol
is effective in preventing refractory chemotherapy associated nausea and vomiting.
Anesthesiology 77:A344, 1992.
225.
Appadu BL, Strange PG, Lambert DG: Does propofol
interact with D2
dopamine receptors? Anesth Analg 79:1191–1192,
1994.
226.
Saiah M, Borgeat A, Wilder-Smith OH, et al: Epidural-morphine-induced
pruritus: Propofol versus naloxone. Anesth Analg 78:1110–1113, 1994.
227.
Leslie K, Sessler DI, Bjorksten AR, et al: Propofol
causes a dose-dependent decrease in the thermoregulatory threshold for vasoconstriction
but has little effect on sweating. Anesthesiology 81:353–360, 1994.
228.
Skoutelis A, Lianou P, Papageorgiou E, et al:
Effects of propofol and thiopentone on polymorphonuclear leukocyte functions in
vitro. Acta Anaesthesiol Scand 38:858–862, 1994.
229.
Krumholz W, Endrass J, Hempelmann G: Propofol
inhibits phagocytosis and killing of Staphylococcus aureus
and Escherichia coli by polymorphonuclear leukocytes
in vitro. Can J Anaesth 41:446–449, 1994.
230.
Bennett SN, McNeil MM, Bland LA, et al: Postoperative
infections traced to contamination of an intravenous anesthetic, propofol. N Engl
J Med 333:147–154, 1995.
231.
Mammoto T, Mukai M, Mammoto A, et al: Intravenous
anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett 184:165–170,
2002.
232.
Donmez A, Arslan G, Pirat A, Demirhan B: Is pancreatitis
a complication of propofol infusion? Eur J Anaesthesiol 16:367–370, 1999.
233.
Cummings GC, Dixon J, Kay NH, et al: Dose requirements
of ICI 35,868 (propofol, 'Diprivan') in a new formulation for induction of anaesthesia.
Anaesthesia 39:1168–1171, 1984.
234.
Kay B, Stephenson DK: Dose-response relationship
for disoprofol (ICI 35868 Diprivan). Comparison with methohexitone. Anaesthesia
36:863–867, 1981.
235.
Rutter DV, Morgan M, Lumley J, Owen R: ICI 35868
(Diprivan): A new intravenous induction agent. A comparison with methohexitone.
Anaesthesia 35:1188–1192, 1980.
236.
Kazama T, Morita K, Ikeda T, et al: Comparison
of predicted induction dose with predetermined physiologic characteristics of patients
and with pharmacokinetic models incorporating those characteristics as covariates.
Anesthesiology 98:299–305, 2003.
237.
Briggs LP, White M: The effects of premedication
on anaesthesia with propofol ('Diprivan'). Postgrad Med J 61(Suppl 3):35–37,
1985.
238.
Steib A, Freys G, Beller JP, et al: Propofol
in elderly high risk patients. A comparison of haemodynamic effects with thiopentone
during induction of anaesthesia. Anaesthesia 43(Suppl):111–114, 1988.
239.
Kazama T, Ikeda K, Morita K, et al: Investigation
of effective anesthesia induction doses using a wide range of infusion rates with
undiluted and diluted propofol. Anesthesiology 92:1017–1028, 2000.
240.
Purcell-Jones G, Yates A, Baker JR, James IG:
Comparison of the induction characteristics of thiopentone and propofol in children.
Br J Anaesth 59:1431–1436, 1987.
241.
Mirakhur RK: Induction characteristics of propofol
in children: Comparison with thiopentone. Anaesthesia 43:593–598, 1988.
242.
Doze VA, Shafer A, White PF: Propofol-nitrous
oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia. Anesthesiology
69:63–71, 1988.
243.
Heath PJ, Kennedy DJ, Ogg TW, et al: Which intravenous
induction agent for day surgery? A comparison of propofol, thiopentone, methohexitone
and etomidate. Anaesthesia 43:365–368, 1988.
244.
Mackenzie N, Grant IS: Propofol ('Diprivan')
for continuous intravenous anaesthesia. A comparison with methohexitone. Postgrad
Med J 61(Suppl 3):70–75, 1985.
245.
Doze VA, Westphal LM, White PF: Comparison of
propofol with methohexital for outpatient anesthesia. Anesth Analg 65:1189–1195,
1986.
246.
Kay B: Propofol and alfentanil infusion. A comparison
with methohexitone and alfentanil for major surgery. Anaesthesia 41:589–595,
1986.
247.
Sear JW, Shaw I, Wolf A, Kay NH: Infusions of
propofol to supplement nitrous oxide-oxygen for the maintenance of anaesthesia.
A comparison with halothane. Anaesthesia 43(Suppl):18–22, 1988.
248.
Van Hemelrijck J, Smith I, White PF: Use of desflurane
for outpatient anesthesia. A comparison with propofol and nitrous oxide. Anesthesiology
75:197–203, 1991.
249.
Roberts FL, Dixon J, Lewis GT, et al: Induction
and maintenance of propofol anaesthesia. A manual infusion scheme. Anaesthesia
43(Suppl):14–17, 1988.
250.
Thomas VL, Sutton DN, Saunders DA: The effect
of fentanyl on propofol requirements for day case anaesthesia. Anaesthesia 43(Suppl):73–75,
1988.
251.
Fehr SB, Zalunardo MP, Seifert B, et al: Clonidine
decreases propofol requirements during anaesthesia: Effect on bispectral index.
Br J Anaesth 86:627–632, 2001.
252.
Wilder-Smith OH, Ravussin PA, Decosterd LA, et
al: Midazolam premedication reduces propofol dose requirements for multiple anesthetic
endpoints. Can J Anaesth 48:439–445, 2001.
253.
Hentgen E, Houfani M, Billard V, et al: Propofol-sufentanil
anesthesia for thyroid surgery: Optimal concentrations for hemodynamic and electroencephalogram
stability, and recovery features. Anesth Analg 95:597–605, 2002.
254.
Taylor IN, Kenny GN, Glen JB: Pharmacodynamic
stability of a mixture of propofol and alfentanil. Br J Anaesth 69:168–171,
1992.
255.
Hilton P, Dev VJ, Major E: Intravenous anaesthesia
with propofol and alfentanil. The influence of age and weight. Anaesthesia 41:640–643,
1986.
256.
Schuttler J, Kloos S, Roepcke H: Age dependent
dose requirements of propofol in total intravenous anesthesia as quantified by closed-loop
EEG feedback infusion strategies. Anesthesiology 77:A338, 1992.
257.
Schuttler J, Kloos S, Schwilden H, Stoeckel H:
Total intravenous anaesthesia with propofol and alfentanil by computer-assisted
infusion. Anaesthesia 43(Suppl):2–7, 1988.
258.
Tackley R, Lewis G, Prys-Roberts C: Open loop
control of propofol infusions [abstract]. Br J Anaesth 59:935, 1987.
259.
Visser K, Hassink EA, Bonsel GJ, et al: Randomized
controlled trial of total intravenous anesthesia with propofol versus inhalation
anesthesia with isoflurane-nitrous oxide: Postoperative nausea with vomiting and
economic analysis. Anesthesiology 95:616–626, 2001.
260.
Dexter F, Tinker JH: Comparisons between desflurane
and isolfurane or propofol on time to following commands and time to discharge.
A metaanalysis. Anesthesiology 83:77–82, 1995.
261.
Russell GN, Wright EL, Fox MA, et al: Propofol-fentanyl
anaesthesia for coronary artery surgery and cardiopulmonary bypass. Anaesthesia
44:205–208, 1989.
262.
Mora C, Dudek C, Epstein R: Cardiac anesthesia
techniques, fentanyl alone or in combination with enflurane or propofol. Anesth
Analg 68:S202, 1989.
263.
Underwood SM, Davies SW, Feneck RO, Walesby RK:
Anaesthesia for myocardial revascularisation. A comparison of fentanyl/propofol
with fentanyl/enflurane. Anaesthesia 47:939–945, 1992.
264.
Hall RI, Murphy JT, Moffitt EA, et al: A comparison
of the myocardial metabolic and haemodynamic changes produced by propofol-sufentanil
and enflurane-sufentanil anaesthesia for patients having coronary artery bypass graft
surgery. Can J Anaesth 38:996–1004, 1991.
265.
Fanard L, Van Steenberge A, Demeire X, van der
Puyl F: Comparison between propofol and midazolam as sedative agents for surgery
under regional anaesthesia. Anaesthesia 43(Suppl):87–89, 1988.
266.
Gepts E, Claeys MA, Camu F, Smekens L: Infusion
of propofol ('Diprivan') as sedative technique for colonoscopies. Postgrad Med J
61(Suppl 3):120–126, 1987.
267.
Newman LH, McDonald JC, Wallace PG, Ledingham
IM: Propofol infusion for sedation in intensive care. Anaesthesia 42:929–937,
1987.
268.
Grounds R, Lalor J, Lumley J: Propofol infusion
for sedation in the intensive care unit: Preliminary report. BMJ (Clin Res Ed)
294:397–400, 1987.
269.
Beller JP, Pottecher T, Mangin P, et al: Prolonged
sedation with propofol in resuscitation. Recovery and pharmacokinetic study. Preliminary
results [in French]. Ann Fr Anesth Reanim 6:334–335, 1987.
270.
Beller JP, Pottecher T, Lugnier A, et al: Prolonged
sedation with propofol in ICU patients: Recovery and blood concentration changes
during periodic interruptions in infusion. Br J Anaesth 61:583–588, 1988.
271.
Parke TJ, Stevens JE, Rice AS, et al: Metabolic
acidosis and fatal myocardial failure after propofol infusion in children: Five
case reports. BMJ 305:613–616, 1992.
272.
Murphy PG, Myers DS, Davies MJ, et al: The antioxidant
potential of propofol (2,6-diisopropylphenol). Br J Anaesth 68:613–618, 1992.
273.
Chong JL, Grebenik C, Sinclair M, et al: The
effect of a cardiac surgical recovery area on the timing of extubation. J Cardiothorac
Vasc Anesth 7:137–141, 1993.
274.
Rudkin GE, Osborne GA, Finn BP, et al: Intra-operative
patient-controlled sedation. Comparison of patient-controlled propofol with patient-controlled
midazolam. Anaesthesia 47:376–381, 1992.
275.
Canessa R, Lema G, Urzua J, et al: Anesthesia
for elective cardioversion: A comparison of four anesthetic agents. J Cardiothorac
Vasc Anesth 5:566–568, 1991.
276.
Kang TM: Propofol infusion syndrome in critically
ill patients. Ann Pharmacother 36:1453–1456, 2002.
277.
Wolf A, Weir P, Segar P, et al: Impaired fatty
acid oxidation in propofol infusion syndrome. Lancet 357:606–607, 2001.
278.
Dundee JW, McIlroy PD: The history of barbiturates.
Anaesthesia 37:726–734, 1982.
279.
Ball C, Westhorpe R: The history of intravenous
anaesthesia: The barbiturates. Part 1. Anaesth Intensive Care 29:97, 2001.
280.
Redonnet T: Recherches comparatives sur l'action
pharmacodynamique des derives de l'acide barbiturique. Arch Int Pharmacodyn Ther
25:27, 1920.
281.
Bardet G, Bardet D: Contribution a l'etudes des
hypnotiques ureiques; action et utilisation du diethyl-diallyl-barbiturate de diethyl-amine.
Bull Gen Ther Med Chir Obstet Pharm 172:173, 1921.
282.
Weese H, Scharpf W: Evipan; ein neuartiges Einschlafmittel.
Dtsch Med Wochenschr 58:1205, 1932.
283.
Ball C, Westhorpe R: The history of intravenous
anaesthesia: The barbiturates. Part 2. Anaesth Intensive Care 29:219, 2001.
284.
Tabern T, Volwiler E: Sulfur-containing barbiturate
hypnotics. J Am Chem Soc 57:1961, 1935.
285.
Corssen G, Reves J, Stanley T: Dissociative anesthesia.
In Corssen G, Reves J, Stanley T (eds): Intravenous
Anesthesia and Analgesia. Philadelphia, Lea & Febiger, 1988, p 99.
286.
Halford F: A critique of intravenous anaesthesia
in war surgery. Anaesthesiology 4:67–69, 1943.
287.
Adams R: Intravenous Anesthesia. New York, Paul
B Hoeber, 1944.
288.
Dundee J, Wyant G: Intravenous Anaesthesia.
Edinburgh, Churchill Livingstone, 1974.
289.
Mahisekar UL, Callan CM, Derasari M, Kirkpatrick
AF: Infusion of large particles of thiopental sodium during anesthesia induction.
J Clin Anesth 6:55–58, 1994.
290.
Wahlstrom G: Differences in anaesthetic properties
between optical antipodes of hexobarbital in the rat. Life Sci 5:1781–1790,
1966.
291.
Andrews PR, Mark LC: Structural specificity of
barbiturates and related drugs. Anesthesiology 57:314–320, 1982.
292.
Nguyen KT, Stephens DP, McLeish MJ, et al: Pharmacokinetics
of thiopental and pentobarbital enantiomers after intravenous administration of racemic
thiopental. Anesth Analg 83:552–558, 1996.
293.
Wahlstrom G, Buch H, Buzello W: Unequal anaesthetic
potency despite equal brain concentration of hexobarbital antipodes. Acta Pharmacol
Toxicol 28:493–498, 1970.
294.
Christensen H, Lee I: Anesthetic potency and
acute toxicity of optically active disubstituted barbituric acids. Toxicol Appl
Pharmacol 26:495–503, 1973.
295.
Raventos J: The distribution in the body and
metabolic fate of barbiturates. J Pharm Pharmacol 6:217, 1954.
296.
Mark L: Metabolism of barbiturates in man. Clin
Pharmacol Ther 4:504, 1963.
297.
Granik S: Induction of the synthesis of d-amino-levulinic
acid synthetase in liver parenchyma cells in culture by chemicals that induce acute
porphyria. J Biol Chem 238:PC2247, 1963.
298.
Sharpless S: Hypnotics and sedatives. In
Goodman LS, Limbird LE, Milinoff PB, et al (eds): The Pharmacological Basis of Therapeutics.
New York, MacMillan, 1970.
299.
Waddell WJ, Butler TC: The distribution and excretion
of phenobarbital. J Clin Invest 36:1217–1226, 1957.
300.
Henthorn T, Avram M, Krejcie T: Intravascular
mixing and drug distribution: The concurrent disposition of thiopental and indocyanine
green. Clin Pharmacol Ther 45:56–65, 1989.
